Skip to content

Today's Technology For Tomorrow's Kidney Care

Intestinal Dialysis™

A Break Through Technology

In transition from Kidney health supplement to a live biotherapeutic product (LBP) development under CBER/USFD approved Investigational New Drug(IND) for multisite RCT, CKD patients (N=630).For more details refer to Clinical Trials. 

Intestinal Dialysis™ (a.k.a Enteric Dialysis®) – Modulating the Gut Microbiome with Probiotics and Prebiotics (Gut-Kidney Connection)

Kibow's - Intestinal Dialysis™

Award winning and patented technology

2020 Business of the Year

Delaware County Chamber of Commerce

Bio - Biotechnology Innovation Organization

2005 - Innovation Corridor Abstract Winner, Boston, MA

2018 - Invited Company for Presentation, Boston, MA

Kibow Buzz of Bio Winner (Kidney Health)

2014 - A “Buzz of Bio" Winner

Pipelines of Promise category, International Bio conference, San Diego, CA

The first dietary supplement Company nominated to participate in the "Buzz of Bio".

2019 - Dun & Bradstreet Award

In recognition of unwavering commitment to business growth

Subscribe Newsletter &

Get Company News

Kibow Pharmaceuticals, LLC is a newly created corporation established in Oct 01 2019. Wholly owned subsidiary of Kibow Biotech Inc.

Company’s vision and mission is to develop Live Biotherapeutic drug for all stages of Chronic Kidney Disease (CKD).

Want to know more? Contact Us

Kibow Pharmaceuticals, LLC
4781 West Chester Pike
Newtown Square, PA 19073


Phone: 610-353-5130 || Fax: 610-353-5110

© Kibow Pharmaceuticals, LLC. All rights reserved.